AusCann (ACNNF)

[MADDSTACKER]

To many damn shares , but huge jv it will bounce Bro just got to wait ...

[brandao]

Got in at the wrong time.

[justaplan]

one reason I'm in with canopy growth and holding long :)

[MADDSTACKER]

Assuming with opioid company ... they supply 40% of world supply , they made a jv with us for a reason :)

[justaplan]

what contract do you speak of

[MADDSTACKER]

Big contract coming here imho !!!!

[CES2002]

Very positive development, would seem to indicate that the time is near for sales to commence.

[OSOROJO]

Canopy Growth Provides Further Updates on Australian Operations
September 13, 2017
D.M.O. Newswire


SMITHS FALLS, ON, Sept. 13, 2017 /CNW/ - Canopy Growth Corporation (TSX:WEED) ("Canopy Growth" or the "Company") is pleased to announce that it has entered into a supply agreement with AusCann Group Holdings Ltd. ("AusCann"), whereby Canopy Growth will act as AusCann's exclusive supplier of medical cannabis for the Australian market, beginning with the transfer of a range of medicines for research and commercialization in Australia.

The Australian market continues to present attractive growth opportunities for medical cannabis and through the Company's minority ownership stake and excellent working relationship with AusCann, it is in a prime position to realize this potential for its shareholders.

"This agreement is a positive step in enabling Australian patients to have access to high quality cannabinoid medications," said Elaine Darby, Managing Director, AusCann. "I'm excited to move forward with this partnership, and continue to utilize the production scale of existing partners to accelerate our own sales function and market presence."

As an emerging market, the size of this initial shipment is not expected to affect registered customer's ability to purchase product through Tweedmainstreet.com where consistent product availability has stabilized thanks to strong production from the Canopy-wide production platform.

This agreement, which continues to allow Canopy Growth to pursue other Australian opportunities, follows a recent announcement issued September 11, 2017, in which the Company announced a strategic partnership with Alcaliber S.A. ("Alcaliber"), a leading pharmaceutical producer that last year exported 125 tonnes of alkaloids to 40 countries around the world, representing a 20% market share for Narcotic Raw Material (NRM).

Whether Europe, South America, Australia, or at home, Canopy Growth is working hard to bring its recognized, high quality genetics to the world.

Here's to Future Growth Down Under.

[CES2002]

Up almost 11% today, Hmmmmmmmmmmm

[justaplan]

Down almost 11% today...HMMMM

[twister1]

brandao keep this one in your long term file box... in the year 2020 you open up the file box and inside will be a big chunk of property with big boom boom all over it.... glta

[justaplan]

Makes 2 of us...better than being too late

[brandao]

Came here too early I think

[MADDSTACKER]

http://www.abc.net.au/news/2017-08-31/medicinal-cannabis-in-tasmania-imminent-but-concerns-linger/8857448

[MADDSTACKER]

There partner supplies 40% of opioids to pharma companies , wonder if there going to supply raw cannabis to pharma !!!!

[MADDSTACKER]

Np :)

[Siormilan]

Thanx for the video!

[MADDSTACKER]

This is why you should buy and hold this stock !!!!!

[Siormilan]

10% up!

[brandao]

Down go the aussies

[brandao]

Solid video... this is only going to grow.

[OSOROJO]

[MADDSTACKER]

Smack the ask .. .05% won't matter in 2018

[brandao]

You think this will catch cann group ltn price

[brandao]

No one is selling to me

[Siormilan]

On high volume!

[OnlyGoLong]

Up 10.5% in Aussie Monday. Cheers

[CES2002]

NEWS
https://thewest.com.au/business/health/wa-medical-cannabis-gets-green-light-ng-b88562325z?utm_source=Australian+Cannabis+Updates&utm_campaign=764ac611c8-EMAIL_CAMPAIGN_2017_08_10&utm_medium=email&utm_term=0_4014b13a3c-764ac611c8-62697039

[ForAllSadWords]

While there's a good run going, I'm sure there will be a pullback, phenomenal news but if you look at Australia you can see there is a pullback today already. I think this will be a 2-3 dollar company (US) within a year or two and as I've previously said, $4-$5 auS would see me retired, I think this is a LONG term play, I see natural growing conditions in Australia that will rival international supply and being so close to asia, there is massive opportunity for expansion and monumental growth in sales. My personal sell target is $5 US

[MADDSTACKER]

Yup looks good

[Siormilan]

Was it?just 500 shares traded now @.44

[MADDSTACKER]

Still halted ?

[Siormilan]

8m shares in aus vs 0 in US...

[MADDSTACKER]

2 license could see $2 before January ....

[Siormilan]

U never know w this one thou..

[MADDSTACKER]

Up .13 in Canada could be making run for $1 this month

[Siormilan]

Wow.it shows 15k.but it has to be yesterday volume still...no one selling...

[MADDSTACKER]

Because no sales yet

[Siormilan]

According to TD...price still @.41 but bid @.44 ?!????

[MADDSTACKER]

Damn what gapp up ...

[Siormilan]

Almost 5m shares!

[OSOROJO]

AusCann Group Holdings Ltd granted Australian medicinal cannabis manufacturing licence
Share
10:22 09 Aug 2017

[ForAllSadWords]

http://www.proactiveinvestors.com.au/companies/news/182085/auscann-group-holdings-to-outline-next-medicinal-cannabis-steps-in-australia-182085.html

So we have a good harvest in South America, successful fund raising (I am informed Auscann are also looking for investors in Asia (that would be a phenomenal market to have links in and to get into) and to me, part owners canopy might be interested in a little more of a stake in this company since the news on US investments owned by Canadian companies.

Also with the partnership with Tasmania alkaloids and their new license, I feel it will be a great report and announcement, I'm hoping for something big but we will see. Could also be a problem with Australian legislation stalling or the reluctance of Australian Dr's to prescribe cannabis and the stigma still attached, Auscann have brought canopys medical educationalist in to tackle that so maybe he's had some success. Maybe not.

All I can say for sure is it's good to hear something from the company.

[twister1]

what does this upcoming halt mean for us shareholders? any info or ideas from other members? thanks and have a great evening

[OSOROJO]

????... 7 August 2017
Company Announcements Australian Securities Exchange Level 40 Central Park 152 - 158 St Georges Terrace Perth WA 6000
Dear Sir/Madam
Request for Trading Halt

Pursuant to ASX Listing Rule 17.1, the Directors of AusCann Group Holdings Limited (ASX:AC8) request an immediate trading halt in the securities of the Company pending release of an announcement regarding an update to the Australian operations.
This trading halt will be in place no later than open of trading on Wednesday, 9 August 2017.
The Company is not aware of any reason why the trading halt should not be granted.
By order of the Board

Susan Hunter Company Secretary
For more information please contact
AusCann Elaine Darby Managing Director [e-mail]
For Investment Enquiries Stewart Washer [e-mail] [phone]
For Media Enquiries Caroline Zielinski Media & Capital Partners [e-mail] [phone]
AusCann Group Holdings Ltd ACN 008 095 207
[phone]
www.auscann.com.au Email: [e-mail]
Phone: [phone]
Registered Office: 85 Carabooda Road, Carabooda, Western Australia, 6033

[ForAllSadWords]

Sounds good to me
https://www.newcannabisventures.com/big-opiate-producer-tasmanian-alkaloids-gains-australian-cannabis-production-license/

[ForAllSadWords]

Slow burner, they're barely a few months into medical legalization and haven't harvested a domestic crop yet, they're basically where canadian companies were a couple years back.
I've spoken to the company and they say revenue is expected for late 2017/ early 2018.

[MisterEnzo]

Why is this Board dead?? Isn't there huge news for testing and researching marijuana in Australia?

[CES2002]

HUGE NEWS!!!
http://www.proactiveinvestors.com.au/companies/news/180640/auscann-group-holdings-ltd-secures-two-licences-180640.html

[OSOROJO]

The Auscann Group Holdings Ltd (ASX: AC8) share price has continued its strong run and is up a further 6% to 46 cents today.

This means the medicinal cannabis company’s shares have jumped over 20% since this time last week.

Why has it jumped?

The rally in AusCann’s shares can be traced back to June 15 when the company announced the key appointment of Dr Danial Schecter as Chief Medical Advisor.

Since the day of this announcement, AusCann’s shares have climbed in excess of 30%.

Investors appear to be optimistic that the appointment of the international medical cannabis expert will help the company succeed in its medical outreach program.

The company aims for the program to educate Australian physicians about the benefits of medicinal cannabis, ultimately allowing them to make an informed decision on whether or how to prescribe cannabinoid medicines.